BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaudhary M, Kumar N, Baldi A, Chandra R, Arockia Babu M, Madan J. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, in silico docking and in vitro cytotoxicity analysis. Journal of Biomolecular Structure and Dynamics 2020;38:200-18. [DOI: 10.1080/07391102.2019.1578264] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 El‐mekabaty A, Sofan MA, Hasel AM, Said SB. Concise Synthesis of Some New Benzothiazole‐Based Heterocycles as Probable Anticancer and Antioxidant Agents. ChemistrySelect 2021;6:2569-75. [DOI: 10.1002/slct.202100372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chaudhary M, Kumar N, Baldi A, Chandra R, Babu MA, Madan J. 4-Bromo-4’-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: in silico -guided analysis, synthesis, and in vitro cytotoxicity. Journal of Biomolecular Structure and Dynamics 2020;38:1335-53. [DOI: 10.1080/07391102.2019.1604266] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
3 Anwer KE, Sayed GH. Conventional and microwave reactions of 1,3‐diaryl‐5,4‐enaminonitrile‐pyrazole derivative with expected antimicrobial and anticancer activities. J Heterocyclic Chem 2020;57:2339-53. [DOI: 10.1002/jhet.3946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bennani FE, Doudach L, Karrouchi K, Tarib A, Rudd CE, Ansar M, Faouzi MEA. Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study. J Biomol Struct Dyn 2022;:1-25. [PMID: 35442150 DOI: 10.1080/07391102.2022.2064915] [Reference Citation Analysis]
5 Kulkarni PS, Sarda SR, Khandebharad AU, Farooqui M, Agrawal BR. Pyrazole Linked-1,2,4-Oxadiazole Derivatives as Potential Pharmacological Agent: Design, Synthesis and Antimicrobial Study. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2072914] [Reference Citation Analysis]
6 Targanski SK, Sousa JR, Pádua GM, Sousa JM, Vieira LC, Soares MA. Larvicidal activity of substituted chalcones against Aedes aegypti (Diptera: Culicidae) and non‐target organisms. Pest Manag Sci 2021;77:325-34. [DOI: 10.1002/ps.6021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 El‐mekabaty A, Etman HA, Mosbah A, Fadda AA. Synthesis and Biological Screening of Some Pyrimidinone‐Based Heterocycles from Enamines. ChemistrySelect 2020;5:7888-94. [DOI: 10.1002/slct.202001760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kumar N, Sood D, van der Spek PJ, Sharma HS, Chandra R. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. J Proteome Res 2020;19:4678-89. [PMID: 32786685 DOI: 10.1021/acs.jproteome.0c00367] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
9 Desai NC, Pandya DD, Jadeja DJ, Panda SK, Rana MK. Design, synthesis, biological evaluation and molecular docking study of novel hybrid of pyrazole and benzimidazoles. Chemical Data Collections 2021;33:100703. [DOI: 10.1016/j.cdc.2021.100703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ashrafizadeh M, Zarrabi A, Hashemi F, Moghadam ER, Hashemi F, Entezari M, Hushmandi K, Mohammadinejad R, Najafi M. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci 2020;256:117984. [PMID: 32593707 DOI: 10.1016/j.lfs.2020.117984] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
11 Kumar N, Sood D, Sharma N, Chandra R. Multiepitope Subunit Vaccine to Evoke Immune Response against Acute Encephalitis. J Chem Inf Model 2020;60:421-33. [PMID: 31873008 DOI: 10.1021/acs.jcim.9b01051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
12 Doğan H, Bahar MR, Çalışkan E, Tekin S, Uslu H, Akman F, Koran K, Sandal S, Görgülü AO. Synthesis and spectroscopic characterizations of hexakis[(1-(4'-oxyphenyl)-3-(substituted-phenyl)prop-2-en-1-one)]cyclotriphosphazenes: their in vitro cytotoxic activity, theoretical analysis and molecular docking studies. J Biomol Struct Dyn 2020;:1-15. [PMID: 33210560 DOI: 10.1080/07391102.2020.1846621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cardoso WB, Mendanha SA. Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors. J Mol Struct 2021;1225:129143. [PMID: 32863430 DOI: 10.1016/j.molstruc.2020.129143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
14 Akhtar W, Marella A, Alam MM, Khan MF, Akhtar M, Anwer T, Khan F, Naematullah M, Azam F, Rizvi MA, Shaquiquzzaman M. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors. Arch Pharm (Weinheim) 2021;354:e2000116. [PMID: 33015829 DOI: 10.1002/ardp.202000116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Meena MK, Kumar D, Jayaraj A, Kumar A, Kumari K, Katata-seru LM, Bahadur I, Kumar V, Sherawat A, Singh P. Designed thiazolidines: an arsenal for the inhibition of nsP3 of CHIKV using molecular docking and MD simulations. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2020.1832918] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Pourhanifeh MH, Darvish M, Tabatabaeian J, Fard MR, Mottaghi R, Azadchehr MJ, Jahanshahi M, Sahebkar A, Mirzaei H. Therapeutic role of curcumin and its novel formulations in gynecological cancers. J Ovarian Res 2020;13:130. [PMID: 33148295 DOI: 10.1186/s13048-020-00731-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 El-Gamal MI, Zaraei SO, Madkour MM, Anbar HS. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects. Molecules 2022;27:330. [PMID: 35011562 DOI: 10.3390/molecules27010330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]